Hyperkalemic Periodic Paralysis; Hypp
Description
The 2 dominantly inherited, clinically similar types of episodic flaccid generalized weakness, HOKPP and HYPP, are distinguished by the changes in serum potassium levels during paralytic attacks. An important clinical difference between the 2 entities is represented by the triggers of attacks of weakness, e.g., HYPP can be provoked by oral potassium administration, whereas this is a remedy for HOKPP. Concurrence of myotonia is found in HYPP but usually not in HOKPP patients (Jurkat-Rott et al., 2000).Jurkatt-Rott and Lehmann-Horn (2007) provided a review of the clinical features, pathogenesis, and therapeutic options for HYPP.
Clinical Features
Top most frequent phenotypes and symptoms related to Hyperkalemic Periodic Paralysis; Hypp
- Global developmental delay
- Short stature
- Microcephaly
- Muscle weakness
- Abnormal facial shape
- Pain
- Skeletal muscle atrophy
- Myopathy
- Clinodactyly
- Constipation
And another 11 symptoms. If you need more information about this disease we can help you.
Incidence and onset information
— Currently we don't have prevalence information about this disease (Not enough data available about incidence and published cases.)— No data available about the known clinical features onset.
Alternative names
Hyperkalemic Periodic Paralysis; Hypp Is also known as adynamia episodica hereditaria with or without myotonia, gamstorp disease.
Researches and researchers
Currently, we don't have any information about doctors, researches or researchers related to this disease. Please contact us if you would like to appear here.Hyperkalemic Periodic Paralysis; Hypp Recommended genes panels
Panel Name, Specifity and genes Tested/covered |
---|
SCN4A (Myotonia) DNA Sequencing Test.
By Athena Diagnostics Inc (United States).
SCN4A
Specificity
100 %
Genes
100 % |
Early Onset Myotonia Evaluation.
By Athena Diagnostics Inc (United States).
SCN4A, CLCN1, DMPK
Specificity
34 %
Genes
100 % |
Myotonic Syndrome Advanced Evaluation.
By Athena Diagnostics Inc (United States).
SCN4A, CNBP, CAV3, CLCN1, DMPK, HSPG2, ATP2A1
Specificity
15 %
Genes
100 % |
Periodic Paralysis Advanced Sequencing Evaluation.
By Athena Diagnostics Inc (United States).
SCN4A, CACNA1S, KCNJ2
Specificity
34 %
Genes
100 % |
Congenital Myasthenic Syndrome Advanced Sequencing Evaluation.
By Athena Diagnostics Inc (United States).
SCN4A, CHAT, CHRNA1, CHRNB1, CHRND, CHRNE, COLQ, DOK7, DPAGT1, AGRN, GFPT1, MUSK, RAPSN
Specificity
8 %
Genes
100 % |
Neuromuscular Disorders Panel.
By Greenwood Genetic Center Diagnostic Laboratories Greenwood Genetic Center (United States).
RYR1, BIN1, SCN4A, SGCA, SGCB, SGCD, SGCE, SGCG, SLC25A4, SUCLA2, SUCLG1, TWNK, TCAP, TIA1, TK2, TNNI2, TNNT1, TPM2, TPM3, MYOT , (...)
View the complete list with 124 more genes
Specificity
1 %
Genes
100 % |
NGS Rhabdomyolysis and Metabolic Myopathies Panel.
By Greenwood Genetic Center Diagnostic Laboratories Greenwood Genetic Center (United States).
RYR1, SCN4A, SLC16A1, SUCLA2, TWNK, TK2, TSFM, LPIN1, SLC25A20, CASQ1, CAV3, RRM2B, FKRP, CPT2, SIL1, CTDP1, ANO5, TSEN54, DGUOK, DMD , (...)
View the complete list with 27 more genes
Specificity
3 %
Genes
100 % |
NGS Rhabdomyolysis and Metabolic Myopathies Panel.
By Greenwood Genetic Center Diagnostic Laboratories Greenwood Genetic Center (United States).
RYR1, SCN4A, SLC16A1, SUCLA2, TWNK, TK2, TSFM, LPIN1, SLC25A20, CASQ1, CAV3, RRM2B, FKRP, CPT2, SIL1, CTDP1, ANO5, TSEN54, DGUOK, DMD , (...)
View the complete list with 27 more genes
Specificity
3 %
Genes
100 % |
You can get up to 120 more panels with our dedicated tool
Learn moreSources and references
You can check the following sources for additional information.
OMIM Rare Disease Symptoms CheckerIf you liked this article maybe you will also find interesting the following in-depth articles about other rare diseases, like MYOGLOBINURIA, ACUTE RECURRENT, AUTOSOMAL RECESSIVE SHORT-RIB THORACIC DYSPLASIA 5 WITH OR WITHOUT POLYDACTYLY; SRTD5 OSTEOGENESIS IMPERFECTA, TYPE IV; OI4 DYSTONIA 1, TORSION, AUTOSOMAL DOMINANT; DYT1 CHROMOSOME 5q DELETION SYNDROME FAMILIAL MELANOMA EHLERS-DANLOS SYNDROME TYPE 2